Recurrent involvement of heterochromatic regions in multiple myeloma-A multicolor FISH study

Leukemia Research

Volumn 34, Issue 8, 2010, Pages 1002-1006

  Lange, Kathrin ^a   Gadzicki, Dorothea ^a   Schlegelberger, Brigitte ^a   Göhring, Gudrun ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Chromosome aberration; Genetic instability; Heterochromatic regions; Isochromosomes; Multicolor FISH; Multiple myeloma

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 1; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 19; CHROMOSOME 1Q; CHROMOSOME 6; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME IDENTIFICATION; CHROMOSOME TRANSLOCATION; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RECURRENT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; RECURRENCE; TRANSLOCATION, GENETIC;

EID: 77953609880     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.10.027     Document Type: Article

References (22)

1. Schilling G., Dierlamm J., Hossfeld D.K. Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance. Hematol Oncol 2005, 23:102-107.
2. Mitelman database of chromosome aberrations in cancer 2009, http://cgap.nci.nih.gov/Chromosomes/Mitelman. F. Mitelman, B. Johannson, F. Mertens (Eds.).
3. Avet-Loiseau H., Attal M., Moreau P., Charbonnel C., Garban F., Hulin C., et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood 2007, 109:3489-3495.
4. Fonseca R., Blood E., Rue M., Harrington D., Oken M.M., Kyle R.A., et al. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 2003, 101:4569-4575.
5. Hanamura I., Stewart J.P., Huang Y., Zhan F., Santra M., Sawyer J.R., et al. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation. Blood 2006, 108:1724-1732.
6. Liebisch P., Dohner H. Cytogenetics and molecular cytogenetics in multiple myeloma. Eur J Cancer 2006, 42:1520-1529.
7. Stewart A.K., Fonseca R. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling. J Clin Oncol 2005, 23:6339-6344.
8. Schlegelberger B., Metzke S., Harder S., Zühlke-Jenisch R., Zhang Y., Siebert R. Classical and molecular cytogenetics of tumor cells. Diagnostic Cytogenetics 1999, 151-185. Springer Verlag. R. Wegener (Ed.).
9. Mitelman F, editor. ISCN: Guidelines for cancer cytogenetics, supplement to an international system for human cytogenetic nomenclature. Basel, Switzerland: S. Karger; 1995.
10. Wilkens L., Gerr H., Gadzicki D., Kreipe H., Schlegelberger B. Standardised fluorescence in situ hybridisation in cytological and histological specimens. Virchows Arch 2005, 447:586-592.
11. Gohring G., Karow A., Steinemann D., Wilkens L., Lichter P., Zeidler C., et al. Chromosomal aberrations in congenital bone marrow failure disorders-an early indicator for leukemogenesis?. Ann Hematol 2007, 86:733-739.
12. Hiller B., Bradtke J., Balz H., Rieder H. CyDAS: a cytogenetic data analysis system. Bioinformatics 2005, 21:1282-1283.
13. Chen L., Li J., Xu W., Qiu H., Zhu Y., Zhang Y., et al. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization. Exp Oncol 2007, 29:116-120.
14. Bargetzi M.J., Muhlematter D., Tichelli A., Jotterand M., Wernli M. Dicentric translocation (9;12) presenting as refractory Philadelphia chromosome-positive acute B-cell lymphoblastic leukemia. Cancer Genet Cytogenet 1999, 113:90-92.
15. Schotta G., Lachner M., Sarma K., Ebert A., Sengupta R., Reuter G., et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Gene Dev 2004, 18:1251-1262.
16. Peters A.H., O'Carroll D., Scherthan H., Mechtler K., Sauer S., Schofer C., et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001, 107:323-337.
17. Chng W.J., Santana-Davila R., Van Wier S.A., Ahmann G.J., Jalal S.M., Bergsagel P.L., et al. Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations. Leukemia 2006, 20:807-813.
18. Sawyer J.R., Tricot G., Lukacs J.L., Binz R.L., Tian E., Barlogie B., et al. Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1q. Genes Chromosomes Cancer 2005, 42:95-106.
19. Raab M.S., Podar K., Breitkreutz I., Richardson P.G., Anderson K.C. Multiple myeloma. Lancet 2009, 374:324-339.
20. Agarwal S., Tafel A.A., Kanaar R. DNA double-strand break repair and chromosome translocations. DNA Repair (Amst) 2006, 5:1075-1081.
21. Zhang Y., Rowley J.D. Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair (Amst) 2006, 5:1282-1297.
22. Yang C., Betti C., Singh S., Toor A., Vaughan A. Impaired NHEJ function in multiple myeloma. Mutat Res 2009, 660:66-73.